Pentoxifylline inhibits granzyme B and perforin expression following T-lymphocyte activation by anti-CD3 antibody

This publication has 31 references indexed in Scilit:

• Pentoxifylline exerts synergistic immunomodulatory effects in combination with dexamethasone or cyclosporin A
  International Journal of Immunopharmacology, 1995
• Fas-mediated cytotoxicity by freshly isolated natural killer cells.
  The Journal of Experimental Medicine, 1995
• Effect of interferon-γ, interleukin-2 and interleukin-4 on cyclosporin-a-mediated inhibition of anti-CD3-induced T-lymphocyte proliferation
  International Journal of Immunopharmacology, 1994
• MODULATION OF CYTOLYTIC T CELL RESPONSES BY HEPARAN SULFATE
  Transplantation, 1994
• Granzyme B and perforin can be used as predictive markers of acute rejection in heart transplantation
  European Journal of Immunology, 1994
• In vitro immunomodulatory effects of pentoxifylline
  Immunology Letters, 1993
• Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1‐ but not type 2‐associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats
  European Journal of Immunology, 1993
• Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations
  Cellular Immunology, 1989
• TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties
  Annual Review of Immunology, 1989
• Pentoxifylline
  Drugs, 1987